Prognostic value of miR-106a and miR-20a in AML patients with chemotherapy or allo-HSCT treatment

Prognostic value of miR-106a and miR-20a in AML patients with chemotherapy or allo-HSCT treatment

Background: MiR-106a and miR-20a (miR-17 family members) are frequently dysregulated in carcinogenesis, but their prognostic significance in acute myeloid leukemia (AML) remains unclear.Methods: We analyzed miR-106a and miR-20a expression in bone marrow from 115 AML patients and 45 healthy controls...

Full description

Saved in:
Bibliographic Details
Main Authors: Yue Liu, Jiayu Liu, Yuehua Feng, Xiaoguang Xu, Yingjie Miao, Huijuan Chen, Yu Zhou, Yijun Pan, Yan Liu, Weiying Gu, Yang Cao
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Hematology
Subjects:
AML
miR-106a
miR-20a
chemotherapy
allo-HSCT
prognosis
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2025.2533577
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items